Innovative Cellular Therapeutics Holdings Ltd (CIK 2095697) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-27). Recent activity: Sell LYEL (44,000 shares), Sell LYEL (38,500 shares), Sell LYEL (10 shares), Sell LYEL (10 shares), Sell LYEL (76,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Lyell Immunopharma, Inc. (LYEL) | 10% Owner | Sell | 44,000 | $0 |
| 2026-07-27 | Lyell Immunopharma, Inc. (LYEL) | 10% Owner | Sell | 38,500 | $0 |
| 2026-07-20 | Lyell Immunopharma, Inc. (LYEL) | 10% Owner | Sell | 10 | $137 |
| 2026-07-17 | Lyell Immunopharma, Inc. (LYEL) | 10% Owner | Sell | 10 | $137 |
| 2026-07-01 | Lyell Immunopharma, Inc. (LYEL) | 10% Owner | Sell | 76,000 | $0 |
| 2026-06-18 | Lyell Immunopharma, Inc. (LYEL) | 10% Owner | Sell | 66,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-27